ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Latest editorial penning from VHIO’s Director and ESMO President, Josep Tabernero: All change: closing the gender gap in oncology

20/11/2018|Comments Off on Latest editorial penning from VHIO’s Director and ESMO President, Josep Tabernero: All change: closing the gender gap in oncology

Launched: EurOPDX Research Infrastructure Trans-national Access grant program

19/11/2018|Comments Off on Launched: EurOPDX Research Infrastructure Trans-national Access grant program

Multicenter phase II study signposts new direction in the treatment of BRCA1/2 mutated advanced breast cancer

19/11/2018|Comments Off on Multicenter phase II study signposts new direction in the treatment of BRCA1/2 mutated advanced breast cancer

Worrisome 5% trend makes the headlines to mark World Pancreatic Cancer Day

15/11/2018|Comments Off on Worrisome 5% trend makes the headlines to mark World Pancreatic Cancer Day

See all news

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO´s Scientific Committee headed by José Baselga. A total of 25 renowned Principal Investigators manage and run VHIO´s major research themes and programs.

BROWSE OUR PIs
Launch our Scientific Report 2016

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
OBRA SOCIAL “LA CAIXA”
INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

FEATURED EVENT 2019
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS